The Effect of Antithrombotics on Hematoma Expansion in Small- to Moderate-Sized Traumatic Intraparenchymal Hemorrhages.

[1]  E. de Guise,et al.  Antithrombotic agents and traumatic brain injury in the elderly population: hemorrhage patterns and outcomes. , 2020, Journal of neurosurgery.

[2]  D. Hanley,et al.  Comparison of Traumatic Intracranial Hemorrhage Expansion and Outcomes Among Patients on Direct Oral Anticoagulants Versus Vitamin k Antagonists , 2020, Neurocritical Care.

[3]  J. Barletta,et al.  The Role of Desmopressin on Hematoma Expansion in Patients with Mild Traumatic Brain Injury Prescribed Pre-injury Antiplatelet Medications , 2020, Neurocritical Care.

[4]  R. Matthews,et al.  Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial , 2019, The Lancet.

[5]  Richard A. Sidwell,et al.  Not all head injured patients on antiplatelet drugs need platelets: Integrating platelet reactivity testing into platelet transfusion guidelines. , 2019, Injury.

[6]  F. Dutheil,et al.  Predictive factors of intracranial bleeding in head trauma patients receiving antiplatelet therapy admitted to an emergency department , 2018, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

[7]  D. Tancredi,et al.  The incidence of traumatic intracranial hemorrhage in head-injured older adults transported by EMS with and without anticoagulant or antiplatelet use. , 2017, Journal of neurotrauma.

[8]  Z. Gokaslan,et al.  Duration of indwelling drain following instrumented posterolateral fusion of the lumbar spine does not predict surgical site infection requiring reoperation , 2017, Journal of Clinical Neuroscience.

[9]  E. Hylek,et al.  Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies. , 2017, Current pharmaceutical design.

[10]  L. Beenen,et al.  Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial , 2016, The Lancet.

[11]  A. Lagares,et al.  Traumatic Intracerebral Hemorrhage: Risk Factors Associated with Progression. , 2015, Journal of neurotrauma.

[12]  D. Okonkwo,et al.  Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients , 2015, The journal of trauma and acute care surgery.

[13]  T. Witham,et al.  Development of postoperative C5 palsy is associated with wider posterior decompressions: an analysis of 41 patients. , 2014, The spine journal : official journal of the North American Spine Society.

[14]  L. Boyer,et al.  Severe non-traumatic bleeding events detected by computed tomography: do anticoagulants and antiplatelet agents have a role? , 2014, Journal of Cardiothoracic Surgery.

[15]  J. Goldstein,et al.  Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding: A Randomized, Plasma-Controlled, Phase IIIb Study , 2013, Circulation.

[16]  S. Zehtabchi,et al.  Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: A systematic review , 2012, The journal of trauma and acute care surgery.

[17]  R. Grubb,et al.  Platelet transfusion: an unnecessary risk for mild traumatic brain injury patients on antiplatelet therapy. , 2011, The Journal of trauma.

[18]  G. Guyatt,et al.  The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial , 2011, The Lancet.

[19]  J. Jallo,et al.  Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review. , 2010, World neurosurgery.

[20]  L. Morrison,et al.  Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. , 2009, The Journal of trauma.

[21]  J. Caron,et al.  Early progression of traumatic cerebral contusions: characterization and risk factors. , 2009, The Journal of trauma.

[22]  L. Shutter,et al.  The impact of preinjury antiplatelet and anticoagulant pharmacotherapy on outcomes in elderly patients with hemorrhagic brain injury. , 2008, Surgery.

[23]  G. Howells,et al.  Predictors of mortality in trauma patients with intracranial hemorrhage on preinjury aspirin or clopidogrel. , 2008, The Journal of trauma.

[24]  F. Archer,et al.  A review of patients who suddenly deteriorate in the presence of paramedics , 2008, BMC emergency medicine.

[25]  R. Narayan,et al.  Progression of traumatic intracerebral hemorrhage: a prospective observational study. , 2008, Journal of neurotrauma.

[26]  G. Howells,et al.  Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage. , 2005, The Journal of trauma.

[27]  V. Mok,et al.  Cerebral microbleeds and white matter changes in patients hospitalized with lacunar infarcts , 2004, Journal of Neurology.

[28]  T Brott,et al.  The ABCs of measuring intracerebral hemorrhage volumes. , 1996, Stroke.

[29]  S. Stein,et al.  Delayed brain injury after head trauma: significance of coagulopathy. , 1992, Neurosurgery.

[30]  E. Chang,et al.  Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury period. , 2006, Neurosurgery.

[31]  D. McArthur,et al.  Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. , 2002, Journal of neurosurgery.